# Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients

> **NCT00437372** · PHASE1 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University** · enrollment: 39 (actual)

## Conditions studied

- Cancer
- Head and Neck Cancer
- Pelvic Cancer
- Nervous System Neoplasms
- Thoracic Neoplasms

## Interventions

- **DRUG:** Sunitinib
- **RADIATION:** External Beam Radiation Therapy

## Key facts

- **NCT ID:** NCT00437372
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2025-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00437372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00437372, "Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00437372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*